Precipio Inc (PRPO)

$15.80 +0.39 (2.56%)
Market Cap 24.95M
Revenue (ttm) 18.53M
Net Income (ttm) -4.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -23.15%
Debt to Equity Ratio 0.01
Volume 7,100
Avg Vol 13,626
Day's Range N/A - N/A
Shares Out 1.62M
Stochastic %K 76%
Beta 1.09
Analysts Strong Buy
Price Target $40.00

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Hav...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 203 787 7888
Address:
4 Science Park, 3rd Floor, New Haven, United States
Awaywithshorts
Awaywithshorts Sep. 4 at 3:01 AM
$PRPO Confident. Ignore the naysayers
0 · Reply
Daniech0514
Daniech0514 Sep. 4 at 2:59 AM
$PRPO long strong. Many favorable signals from this company. Likely to continue upward momentum into next year, but thinly traded so buyer beware
0 · Reply
houtx1
houtx1 Sep. 3 at 1:28 PM
$PRPO Sometimes sellers are hidden so its not visible on L2. Sometimes a seller can show up for a second and then remove their shares spoofing which is illegal(happens on bid or ask). I look at who wins at the important levels. I saw sellers at 16 a few days ago, so I keep that Level as a mental note even tbough I couldnt see them yesterday. They stay hidden sometimes so they can unload shares to unknowing buyers who just look at the chart or L2.
0 · Reply
Loren77
Loren77 Sep. 3 at 12:50 PM
$PRPO after the closing of the warrants... Precipio, Inc. terminates its ATM instrument, citing improved financial position and confidence in capital raises. buyout coming? 😸
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 3 at 11:02 AM
$PRPO Waaaay under valued ! Strong financials. Just shows that our market is corrupt.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 3 at 10:08 AM
$PRPO Really good write-up that perfectly summarizes PRPO's present situation. So if you want to bring your PRPO knowledge up to date or just discover PRPO, this is required reading. https://beyondspx.com/quote/PRPO/precipio-the-precision-play-in-cancer-diagnostics-shifts-to-offense-nasdaq-prpo#analysis
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 11:51 PM
$PRPO Should be $50
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 11:35 PM
$PRPO This needs to hit the scanners. This is a bargain. It’s worth 3 times more
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 7:51 PM
$PRPO Needs exposure. Once news of this company hits the wires, it will be epic
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 3:17 PM
$PRPO GREAT NEWS. “Our Company is in a much stronger position today than it was when we entered into this structure. With our elimination of negative cash flow from operations, and our recent increases of our cash balance, we now have confidence that we no longer have to rely on a tool like this for capital raises for the Company”, said Ilan Danieli, Precipio’s
0 · Reply
Latest News on PRPO
Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 9:03 PM EDT - 20 days ago

Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

Precipio Announces its Q2-2025 Financial Results

Aug 13, 2025, 5:00 PM EDT - 21 days ago

Precipio Announces its Q2-2025 Financial Results

Precipio Announces Q2-2025 Shareholder Update Call

Jul 31, 2025, 4:30 PM EDT - 4 weeks ago

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Jul 11, 2025, 4:30 PM EDT - 7 weeks ago

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

May 15, 2025, 6:02 PM EDT - 3 months ago

Precipio, Inc. (PRPO) Q1 2025 Earnings Call Transcript

Precipio Announces its Q1-2025 Financial Results

May 14, 2025, 5:00 PM EDT - 4 months ago

Precipio Announces its Q1-2025 Financial Results

Precipio Announces Q1-2025 Shareholder Update Call

May 1, 2025, 5:00 PM EDT - 4 months ago

Precipio Announces Q1-2025 Shareholder Update Call

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 10:50 PM EDT - 5 months ago

Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Mar 17, 2025, 5:00 PM EDT - 6 months ago

Precipio Announces Q4 and year-end 2024 Shareholder Update Call

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Feb 25, 2025, 9:30 AM EST - 6 months ago

Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Jan 16, 2025, 5:00 PM EST - 8 months ago

Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Nov 18, 2024, 6:16 PM EST - 10 months ago

Precipio, Inc. (PRPO) Q3 2024 Earnings Call Transcript

Precipio Announces Q3-2024 Shareholder Update Call

Nov 6, 2024, 5:00 PM EST - 10 months ago

Precipio Announces Q3-2024 Shareholder Update Call

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Oct 8, 2024, 10:00 AM EDT - 11 months ago

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

Precipio Announces Employee Stock Option Plan Repricing

Sep 6, 2024, 4:00 PM EDT - 1 year ago

Precipio Announces Employee Stock Option Plan Repricing

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Aug 19, 2024, 5:55 PM EDT - 1 year ago

Precipio, Inc. (PRPO) Q2 2024 Earnings Call Transcript

Precipio Announces Q2-2024 Shareholder Update Call

Aug 15, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Q2-2024 Shareholder Update Call

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Jul 25, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Jul 17, 2024, 9:00 AM EDT - 1 year ago

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Jun 13, 2024, 4:00 PM EDT - 1 year ago

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Jun 12, 2024, 4:00 PM EDT - 1 year ago

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

Precipio Secures a short-term $500K Credit Facility

May 6, 2024, 5:00 PM EDT - 1 year ago

Precipio Secures a short-term $500K Credit Facility

Precipio Announces Year end 2023 Shareholder Update Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Precipio Announces Year end 2023 Shareholder Update Call

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Feb 13, 2024, 10:00 AM EST - 1 year ago

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Feb 6, 2024, 10:00 AM EST - 1 year ago

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Jan 23, 2024, 10:00 AM EST - 1 year ago

Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Jan 17, 2024, 10:30 AM EST - 1 year ago

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Precipio Announces Christina Valauri joins the Board of Directors

Jan 2, 2024, 9:00 AM EST - 1 year ago

Precipio Announces Christina Valauri joins the Board of Directors

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Dec 14, 2023, 4:30 PM EST - 1 year ago

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Nov 20, 2023, 6:38 PM EST - 1 year ago

Precipio, Inc. (PRPO) Q3 2023 Earnings Call Transcript

Precipio Announces Q3-2023 Shareholder Update Call

Nov 16, 2023, 5:00 PM EST - 1 year ago

Precipio Announces Q3-2023 Shareholder Update Call

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Oct 18, 2023, 9:00 AM EDT - 2 years ago

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Oct 3, 2023, 10:00 AM EDT - 2 years ago

Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023

Precipio Continues to Sign New HemeScreen™ Customers

Sep 28, 2023, 9:00 AM EDT - 2 years ago

Precipio Continues to Sign New HemeScreen™ Customers

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Sep 25, 2023, 11:00 AM EDT - 2 years ago

Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Sep 21, 2023, 9:00 AM EDT - 2 years ago

Precipio Takes Final Step Towards Regaining Nasdaq Compliance

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Sep 13, 2023, 9:30 AM EDT - 2 years ago

Precipio's Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Aug 17, 2023, 6:32 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript

Precipio Announces Q2-2023 Shareholder Update Call

Aug 10, 2023, 5:00 PM EDT - 2 years ago

Precipio Announces Q2-2023 Shareholder Update Call

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Aug 8, 2023, 9:00 AM EDT - 2 years ago

Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Aug 3, 2023, 9:00 AM EDT - 2 years ago

Precipio's Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Aug 1, 2023, 9:00 AM EDT - 2 years ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Jun 14, 2023, 9:49 AM EDT - 2 years ago

Precipio's Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Jun 13, 2023, 9:00 AM EDT - 2 years ago

Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Jun 8, 2023, 8:30 AM EDT - 2 years ago

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Jun 7, 2023, 9:30 AM EDT - 2 years ago

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

May 22, 2023, 11:00 AM EDT - 2 years ago

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript

May 18, 2023, 12:34 PM EDT - 2 years ago

Precipio, Inc. (PRPO) Q1 2023 Earnings Call Transcript

Precipio Shares Growth Catalysts For HemeScreen

May 17, 2023, 4:00 PM EDT - 2 years ago

Precipio Shares Growth Catalysts For HemeScreen

Precipio Announces Q1-2023 Shareholder Update Call

May 15, 2023, 4:00 PM EDT - 2 years ago

Precipio Announces Q1-2023 Shareholder Update Call

Awaywithshorts
Awaywithshorts Sep. 4 at 3:01 AM
$PRPO Confident. Ignore the naysayers
0 · Reply
Daniech0514
Daniech0514 Sep. 4 at 2:59 AM
$PRPO long strong. Many favorable signals from this company. Likely to continue upward momentum into next year, but thinly traded so buyer beware
0 · Reply
houtx1
houtx1 Sep. 3 at 1:28 PM
$PRPO Sometimes sellers are hidden so its not visible on L2. Sometimes a seller can show up for a second and then remove their shares spoofing which is illegal(happens on bid or ask). I look at who wins at the important levels. I saw sellers at 16 a few days ago, so I keep that Level as a mental note even tbough I couldnt see them yesterday. They stay hidden sometimes so they can unload shares to unknowing buyers who just look at the chart or L2.
0 · Reply
Loren77
Loren77 Sep. 3 at 12:50 PM
$PRPO after the closing of the warrants... Precipio, Inc. terminates its ATM instrument, citing improved financial position and confidence in capital raises. buyout coming? 😸
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 3 at 11:02 AM
$PRPO Waaaay under valued ! Strong financials. Just shows that our market is corrupt.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 3 at 10:08 AM
$PRPO Really good write-up that perfectly summarizes PRPO's present situation. So if you want to bring your PRPO knowledge up to date or just discover PRPO, this is required reading. https://beyondspx.com/quote/PRPO/precipio-the-precision-play-in-cancer-diagnostics-shifts-to-offense-nasdaq-prpo#analysis
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 11:51 PM
$PRPO Should be $50
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 11:35 PM
$PRPO This needs to hit the scanners. This is a bargain. It’s worth 3 times more
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 7:51 PM
$PRPO Needs exposure. Once news of this company hits the wires, it will be epic
0 · Reply
Awaywithshorts
Awaywithshorts Sep. 2 at 3:17 PM
$PRPO GREAT NEWS. “Our Company is in a much stronger position today than it was when we entered into this structure. With our elimination of negative cash flow from operations, and our recent increases of our cash balance, we now have confidence that we no longer have to rely on a tool like this for capital raises for the Company”, said Ilan Danieli, Precipio’s
0 · Reply
DARKP00L
DARKP00L Sep. 2 at 2:22 PM
$PRPO 10:05 on Sep. 02 2025 Precipio Terminates At-The-Market Instrument With Investment Bank Alliance Global Partners #tradeideas
1 · Reply
houtx1
houtx1 Sep. 2 at 2:21 PM
$PRPO chart! The seller at 17 has at least 12k shares waiting to unload. The bid ask spread is very wide at the moment, bid 15.25. So far sellers are dumping if the ask gets hit. I would like to see bid support move a above 16. The sp is 15.80 at this time. The psych level of 16 is important for bulls to close above eod. JMO
1 · Reply
imatisse
imatisse Aug. 31 at 9:13 PM
$PRPO $40
0 · Reply
xbizo
xbizo Aug. 29 at 8:36 PM
$PRPO Valuation is essentially at 1x revenue. With breakeven behind, this should re-rate to at least 3x revenue, and with 30% growth for a few quarters, 7x revenue. Just needs visibility.
0 · Reply
houtx1
houtx1 Aug. 29 at 2:23 PM
$PRPO Im not seeing the seller at 16 but he might be hiding his shares so this is a key level to break above. Seller at 17 still there with at least 12k shares.
0 · Reply
Awaywithshorts
Awaywithshorts Aug. 28 at 10:45 PM
$PRPO
0 · Reply
houtx1
houtx1 Aug. 28 at 2:50 PM
$PRPO at the moment , im not seeing the big seller at 16. The big seller at 17 is there waiting. This will be a big resistance area to keep watch.JMO
0 · Reply
s7w
s7w Aug. 28 at 2:40 PM
$PRPO
0 · Reply
Awaywithshorts
Awaywithshorts Aug. 28 at 11:56 AM
$PRPO Confident
0 · Reply
houtx1
houtx1 Aug. 28 at 12:01 AM
$PRPO Bullish day! A seller came in a few hours after the open around 15.90 with at least 4k shares. That put a limit on how high buyers were able to push it up. Its possible the warrant holder is trying to unload shares at these higher prices but so far he isnt undercutting the market. The trading volume was much higher than the last several days so it seems new buyers are showing up. I see sellers at 16 and 17, so these areas are significant to watch. JMO
0 · Reply
eddiel
eddiel Aug. 27 at 7:46 PM
$PRPO keep up dont want to see this close red today.
0 · Reply
Messi0321
Messi0321 Aug. 27 at 5:36 PM
$PRPO 🤑🤫🫣
0 · Reply